OZYMF

ORPHAZYME AS ALMINDIG by Orphazyme A S (OZYMF)

About ORPHAZYME AS ALMINDIG by Orphazyme A S (OZYMF)

Strategic Partners A/S is a biopharmaceutical company, which engages in the research and development of treatments for rare diseases. It provides Arimoclomol program and molecular entities program. The company was founded by Anders Morkeberg Hinsby, Marja Jaattela, Martin Rahbek Kornum, and Thomas Kirkegaard Jensen in 2009 and is headquartered in Copenhagen, Denmark.

Details

Daily high
$91.00
Daily low
$0.10
Price at open
--
52 Week High
$91.00
52 Week Low
$0.09
Market cap
3,800
Dividend yield
0.00%
Volume
0
Avg. volume
0
P/E ratio
-.08

ORPHAZYME AS ALMINDIG by Orphazyme A S News

Details

Daily high
$91.00
Daily low
$0.10
Price at open
--
52 Week High
$91.00
52 Week Low
$0.09
Market cap
3,800
Dividend yield
0.00%
Volume
0
Avg. volume
0
P/E ratio
-.08